Genmab A/S
GNMSF
$274.75
$9.913.74%
OTC PK
| 12/31/2025 | 06/30/2025 | 03/31/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 31.00M | 336.00M | 195.00M | 195.00M | 577.85M |
| Total Depreciation and Amortization | 7.00M | 16.00M | 16.00M | 16.00M | 10.63M |
| Total Amortization of Deferred Charges | 14.00M | -- | -- | -- | 8.00M |
| Total Other Non-Cash Items | -4.00M | -185.00M | 1.00M | 1.00M | -174.01M |
| Change in Net Operating Assets | 253.00M | -105.00M | 75.00M | 75.00M | 1.22M |
| Cash from Operations | 301.00M | 62.00M | 287.00M | 287.00M | 423.70M |
| Capital Expenditure | -13.00M | -10.00M | -12.00M | -12.00M | -14.09M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -7.22B | -- | -- | -- | -82.99M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1.66B | 36.00M | -31.00M | -31.00M | 36.77M |
| Cash from Investing | -5.57B | 26.00M | -43.00M | -43.00M | -60.31M |
| Total Debt Issued | 5.50B | -- | -- | -- | -- |
| Total Debt Repaid | -2.00M | -4.00M | -2.00M | -2.00M | -670.70K |
| Issuance of Common Stock | 7.00M | 6.00M | 1.00M | 1.00M | 2.62M |
| Repurchase of Common Stock | -3.00M | -408.00M | -12.00M | -12.00M | -23.49M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -273.00M | -- | -- | -- | -- |
| Cash from Financing | 5.23B | -406.00M | -13.00M | -13.00M | -21.54M |
| Foreign Exchange rate Adjustments | -4.00M | -5.00M | 8.00M | 8.00M | 17.61M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -46.00M | -323.00M | 239.00M | 239.00M | 359.46M |